Some Medicare Part D recipients will soon be eligible to have weight loss medication Wegovy covered by their plan, the agency said in a statement.
According to guidance provided by the Centers for Medicare and Medicaid Services, FDA-approved anti-obesity medications can be used for an additional medically accepted indication. The FDA said anti-obesity medications like Wegovy will be covered"to treat diabetes or reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.
“Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,” said Dr. John Sharretts of the FDA’s Center for Drug Evaluation and Research. “This patient population has a higher risk of cardiovascular death, heart attack and stroke. Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.
According to KFF, 50 million out of 65 million Medicare recipients are signed up for Part D coverage.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: abc15 - 🏆 263. / 63 Read more »
Source: 10News - 🏆 732. / 50 Read more »
Source: 10News - 🏆 732. / 50 Read more »
Source: WEWS - 🏆 323. / 59 Read more »
Source: 10News - 🏆 732. / 50 Read more »